Biotricity Inc. SEC filings BTCY

Biotricity Inc. has 317 filings in SEC EDGAR's recent list, going back to Jan 27, 2015. Its latest annual report, Form 10-K, was filed on Jul 14, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (officer or director change). The company's fiscal year ends on March 31.

Form Description Filed Period
DEF 14C Information statement Jun 16, 2026 Jun 15, 2026
PRE 14C Filing May 29, 2026 May 29, 2026
DEF 14A Proxy statement Aug 5, 2024 Aug 2, 2024
DEFA14A Additional proxy material Aug 5, 2024 —
PRE 14A Preliminary proxy statement Jul 24, 2024 Jul 24, 2024
DEF 14A Proxy statement Jun 28, 2024 Jun 28, 2024
PRE 14A Preliminary proxy statement Jun 18, 2024 Jun 18, 2024
DEFA14A Additional proxy material Mar 22, 2023 —
DEF 14A Proxy statement Mar 13, 2023 Mar 13, 2023
PRE 14A Preliminary proxy statement Mar 2, 2023 Mar 2, 2023

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BTCY (OTC)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1630113
Former names
METASOLUTIONS, INC. (until Jan 5, 2016)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.